Atlas Trials

Bridge Biotherapeutics, Inc.

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Bridge Biotherapeutics, Inc.

RecordFirmDate
First-in-Human Study of BBT-207 in Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation After Treatment With EGFR TKI (NCT05920135)Bridge Biotherapeutics, Inc.2023-09-11
To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF (NCT05483907)Bridge Biotherapeutics, Inc.2023-04-12
Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative Colitis (NCT04596293)Bridge Biotherapeutics, Inc.2021-06-11
Efficacy and Safety of Rectally Administered BBT-401-1S in Subjects With Ulcerative Colitis (NCT04478825)Bridge Biotherapeutics, Inc.2021-06-01
Phase 1/2 Study of BBT-176 in Advanced NSCLC With Progression After EGFR TKI Treatment (NCT04820023)Bridge Biotherapeutics, Inc.2021-04-02
Evaluate Safety, Pharmacokinetics and Pharmacodynamics of BBT-877 in Healthy Japanese Male (NCT04138849)Bridge Biotherapeutics, Inc.2019-10-01
Assess the Drug Interactions of BBT-877 and Midazolam, Itraconazole, and Esomeprazole in Healthy Adult Subjects (NCT04138836)Bridge Biotherapeutics, Inc.2019-09-17
Efficacy and Safety of BBT-401-1S in Ulcerative Colitis (NCT03800420)Bridge Biotherapeutics, Inc.2019-04-22
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BBT-877 in Healthy Subjects (NCT03830125)Bridge Biotherapeutics, Inc.2019-02-13
First-In-Human Study of BBT-401-1S Following Single and Multiple Ascending Doses in Healthy Volunteers (NCT03482648)Bridge Biotherapeutics, Inc.2018-03-20

Track Bridge Biotherapeutics, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.